Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Baker Felix
Relationship:   Director, 10% Owner
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   20    
Direct Shares   927,207    

Indirect Shares

  141,861,898      
Direct Value   $81,660,525    

Indirect Value

  $12,932,114,466      
Total Shares   142,789,105      
Total Value   $13,013,774,992      


Incyte Corp
 $32,141,876 Seagen Inc
 $49,182,531 Synageva BioPharma Corp
 $0 Genomic Health Inc
 $18,271 Biocryst Pharmaceuticals Inc
 $301,214 Neurogene
 $16,634 Incyte Corp
 $32,141,876 Seagen Inc
 $49,182,531 Synageva BioPharma Corp
 $0 Genomic Health Inc
 $18,271 Biocryst Pharmaceuticals Inc
 $301,214 Neurogene
 $16,634
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    36   
    6    

     Stock price went up :

    15   
    6    
     Stock price went down :
    21   
    0    
   
     Gain/Loss Ratio :
   0.0   
   6.0   
     Percentage Gain/Loss :
   -24.3%
 18.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Incyte Corp INCY Director, 10% Owner 2023-09-29 559,963 2023-09-29 33,480,292    Premium*  
            Ardea Biosciences Inc RDEA Director, 10% Owner 2003-10-06 0 2012-02-01 116,454    Premium*  
            Seagen Inc SGEN Director, 10% Owner 2018-02-01 215,015 2018-02-01 44,355,335    Premium*  
            Synageva BioPharma Corp GEVA Director, 10% Owner 2015-06-22 100,503 2015-06-22 9,328,233    Premium*  
            Viropharma Inc VPHM 10% Owner 2005-01-31 0 2011-12-14 303,264    Premium*  
            Aceragen, Inc ACGN Director 0 2017-07-03 145,453    Premium*  
            Tapestry Pharmaceuticals Inc TPPHQ 10% Owner 0 2008-10-15 0    Premium*  
            Genomic Health Inc GHDX Director, 10% Owner 2012-10-01 288 2012-10-01 11,377,485    Premium*  
            Allos Therapeutics Inc ALTH 10% Owner 0 2009-02-06 1,629    Premium*  
            Biocryst Pharmaceuticals Inc BCRX 10% Owner 2016-08-16 46,918 2016-08-16 9,418,390    Premium*  
            Heron Therapeutics Inc HRTX 10% Owner 0 2011-06-30 5,266,568    Premium*  
            Adolor Corp ADLR 10% Owner 2010-04-26 0 2011-12-19 0    Premium*  
            Diadexus Inc DDXS 10% Owner 0 2010-07-28 140,525    Premium*  
            Pharmacyclics Inc PCYC 10% Owner 0 2011-08-22 1,809    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2012-03-12 0 2012-03-14 57,704    Premium*  
            XOMA Corporation XOMA Director, 10% Owner 2012-10-29 0 2012-10-29 480,639    Premium*  
            Neurogene NGNE 10% Owner 2015-08-07 4,520 0    Premium*  
            Invitae Corp NVTA 10% Owner 0 2015-08-27 6,554,967    Premium*  
            Bellicum Pharmaceuticals, Inc BLCM 10% Owner 0 2015-12-24 4,865,647    Premium*  
            Kodiak Sciences Inc. KOD Director, 10% Owner 2022-01-21 0 2022-06-06 15,967,504    Premium*  
* Premium Members only  

Records found :    1397         Free Registration Required For Full Results.    Limit: 25

Download
  Page 47 of 56
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
ACGN Aceragen, Inc 10% Owner   –       –       •   2007-11-07 4 S $12.66 $617,006 I/I (48,744) 1,151,014 0 -
KOD Kodiak Sciences Inc. Director   –       •       •   2022-05-26 4 B $6.71 $628,583 I/I 93,322 15,316,021 2.25 %
VPHM Viropharma Inc 10% Owner   –       –       •   2008-01-09 4 B $8.95 $630,399 I/I 70,449 4,952,506 1.5 -
GHDX Genomic Health Inc Director   –       •       •   2010-02-09 4 B $16.93 $632,501 I/I 36,992 3,936,781 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2009-05-20 4 B $17.88 $635,637 I/I 35,341 3,664,999 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2010-08-06 4 B $14.16 $636,250 I/I 44,927 4,345,671 2.25 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2006-11-16 4 B $5.80 $641,528 I/I 110,553 4,190,587 1.5 -
GHDX Genomic Health Inc Director   –       •       •   2012-02-16 4 B $28.96 $651,092 I/I 21,900 1,406,049 2.25 -
VPHM Viropharma Inc 10% Owner   –       –       •   2011-09-23 4 B $17.58 $651,492 I/I 36,728 1,816,749 1.5 -
GHDX Genomic Health Inc Director   –       •       •   2012-02-10 4 B $26.52 $653,635 I/I 24,582 1,372,864 2.25 -
BCRX Biocryst Pharmaceuticals ... 10% Owner   –       –       •   2016-01-19 4 B $7.12 $656,750 I/I 92,200 12,393,685 1.5 -
GHDX Genomic Health Inc Director   –       •       •   2012-03-07 4 B $29.88 $659,464 I/I 22,071 8,235,908 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2011-11-16 4 B $27.24 $663,310 I/I 24,256 6,590,213 2.25 -
KOD Kodiak Sciences Inc. Director   –       •       •   2022-05-17 4 B $5.99 $663,571 I/I 110,824 14,942,601 2.25 %
KOD Kodiak Sciences Inc. Director   –       •       •   2022-05-25 4 B $6.53 $664,135 I/I 101,144 15,232,546 2.25 %
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2008-01-14 4 B $7.41 $664,603 I/I 89,632 6,470,110 1.5 -
GHDX Genomic Health Inc Director   –       •       •   2010-08-30 4 B $14.44 $665,223 I/I 46,047 4,864,263 2.25 -
VPHM Viropharma Inc 10% Owner   –       –       •   2010-05-10 4 S $12.70 $666,930 I/I (52,508) 248,829 0 -
ADLR Adolor Corp 10% Owner   –       –       •   2010-06-01 4 B $1.58 $668,272 I/I 407,639 6,840,421 1.5 -
GHDX Genomic Health Inc Director   –       •       •   2007-05-25 4 B $16.24 $680,782 I/I 41,909 1,110,832 2.25 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2006-11-15 4 B $5.66 $682,811 I/I 120,702 1,570,635 1.5 -
KOD Kodiak Sciences Inc. Director   –       •       •   2022-05-16 4 B $5.71 $697,839 I/I 122,100 14,843,809 2.25 %
GHDX Genomic Health Inc Director   –       •       •   2010-08-13 4 B $14.81 $703,529 I/I 47,408 4,570,896 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2011-12-01 4 B $27.33 $725,256 I/I 26,537 1,286,841 2.25 -
VPHM Viropharma Inc 10% Owner   –       –       •   2007-04-17 4 S $15.43 $726,394 I/I (47,053) 1,786,851 0 -

  1397  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34   35   36   37   38   39   40   41   42   43   44   45   46   47  48   49   50   51   52   53   54   55   56      
  Page 47 of 56  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed